The Chicago Entrepreneur

Calliditas Therapeutics’ stock surges after $1.1 billion takeover bid

Calliditas Therapeutics’ American depositary receipts jumped more than 70% premarket on Tuesday after a nearly $1.1 billion takeover bid from a Japanese conglomerate.

Previous post You don’t have to be dead to use life insurance. It can also fund long-term care.
Next post Energy Transfer to pay more than $3 billion to expand its Permian pipeline